Compare Pfizer with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs WOCKHARDT - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

WOCKHARDT 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER WOCKHARDT PFIZER/
WOCKHARDT
 
P/E (TTM) x 32.7 -19.5 - View Chart
P/BV x 5.5 1.0 534.2% View Chart
Dividend Yield % 0.6 0.0 16,546.8%  

Financials

 PFIZER   WOCKHARDT
EQUITY SHARE DATA
    PFIZER
Mar-18
WOCKHARDT
Mar-18
PFIZER/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs2,3651,012 233.7%   
Low Rs1,625532 305.7%   
Sales per share (Unadj.) Rs430.3355.9 120.9%  
Earnings per share (Unadj.) Rs78.7-60.3 -130.6%  
Cash flow per share (Unadj.) Rs93.2-46.8 -199.3%  
Dividends per share (Unadj.) Rs20.000.01 200,000.0%  
Dividend yield (eoy) %1.00 77,368.4%  
Book value per share (Unadj.) Rs586.5257.8 227.5%  
Shares outstanding (eoy) m45.75110.63 41.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.62.2 213.8%   
Avg P/E ratio x25.3-12.8 -198.0%  
P/CF ratio (eoy) x21.4-16.5 -129.7%  
Price / Book Value ratio x3.43.0 113.6%  
Dividend payout %25.40 -153,175.5%   
Avg Mkt Cap Rs m91,27185,379 106.9%   
No. of employees `0002.66.3 42.1%   
Total wages/salary Rs m3,1439,371 33.5%   
Avg. sales/employee Rs Th7,484.86,295.0 118.9%   
Avg. wages/employee Rs Th1,195.01,498.3 79.8%   
Avg. net profit/employee Rs Th1,369.1-1,066.3 -128.4%   
INCOME DATA
Net Sales Rs m19,68539,369 50.0%  
Other income Rs m1,1431,202 95.1%   
Total revenues Rs m20,82840,571 51.3%   
Gross profit Rs m5,00318 27,338.3%  
Depreciation Rs m6631,495 44.3%   
Interest Rs m42,555 0.2%   
Profit before tax Rs m5,479-2,830 -193.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3,582 0.0%   
Tax Rs m1,878257 730.9%   
Profit after tax Rs m3,601-6,669 -54.0%  
Gross profit margin %25.40 54,674.8%  
Effective tax rate %34.3-9.1 -377.5%   
Net profit margin %18.3-16.9 -108.0%  
BALANCE SHEET DATA
Current assets Rs m24,16733,796 71.5%   
Current liabilities Rs m9,54426,917 35.5%   
Net working cap to sales %74.317.5 425.1%  
Current ratio x2.51.3 201.7%  
Inventory Days Days5579 69.4%  
Debtors Days Days2989 32.2%  
Net fixed assets Rs m9,51439,664 24.0%   
Share capital Rs m458553 82.7%   
"Free" reserves Rs m26,37527,968 94.3%   
Net worth Rs m26,83228,522 94.1%   
Long term debt Rs m2521,731 0.1%   
Total assets Rs m36,90081,620 45.2%  
Interest coverage x1,305.5-0.1 -1,214,249.6%   
Debt to equity ratio x00.8 0.1%  
Sales to assets ratio x0.50.5 110.6%   
Return on assets %9.8-5.0 -193.8%  
Return on equity %13.4-23.4 -57.4%  
Return on capital %20.4-7.7 -266.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m229,807 0.2%   
Fx outflow Rs m1,4891,789 83.2%   
Net fx Rs m-1,4668,019 -18.3%   
CASH FLOW
From Operations Rs m3,318684 484.8%  
From Investments Rs m-2,3836,302 -37.8%  
From Financial Activity Rs m-1,104-7,695 14.3%  
Net Cashflow Rs m-169-664 25.4%  

Share Holding

Indian Promoters % 0.0 74.5 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 2.3 326.1%  
FIIs % 4.9 7.7 63.6%  
ADR/GDR % 0.0 0.1 -  
Free float % 23.7 15.4 153.9%  
Shareholders   85,207 67,757 125.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   AUROBINDO PHARMA  ORCHID PHARMA LTD  NOVARTIS  J.B.CHEMICALS  PROCTER & GAMBLE HEALTH  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (3QFY19); Net Profit Down 80.6% (Quarterly Result Update)

Jan 29, 2019 | Updated on Jan 29, 2019

For the quarter ended December 2018, WOCKHARDT LTD. has posted a net profit of Rs 769 m (down 80.6% YoY). Sales on the other hand came in at Rs 10 bn (up 4.0% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Oct 18, 2019 (Close)

TRACK PFIZER

PFIZER - GLENMARK PHARMA COMPARISON

COMPARE PFIZER WITH

MARKET STATS